Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z003766 | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
A pharmacist called and reported that an improperly stored dose of VARIVAX was administered to a patient. The caller did not have any other additional information to add to further clarify the details, including patient demographics or the dates of a; No adverse event; This spontaneous report was received from a/an Pharmacist and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z003766, expiration date: 30-Jan-2027) administered by Unknown route. The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), for the treatment of Prophylaxis. On an unknown date, the patient experienced A pharmacist called and reported that an improperly stored dose of VARIVAX was administered to a patient. The caller did not have any other additional information to add to further clarify the details, including patient demographics or the dates of a. On an unknown date, the patient experienced No adverse event. At the reporting time, the outcome of A pharmacist called and reported that an improperly stored dose of VARIVAX was administered to a patient. The caller did not have any other additional information to add to further clarify the details, including patient demographics or the dates of a and No adverse event was unknown. The action taken with Varicella Virus Vaccine Live (Oka-Merck) was reported as not applicable. The case ws determined to be non-valid due to lack of patient's identifiers.